Please login to the form below

Not currently logged in
Email:
Password:

Sir Philip Hampton set to be new GSK chair

RBS chairman to replace Sir Christopher Gent

philip hampton gskGlaxoSmithKline (GSK) is set to name the Royal Bank of Scotland's (RBS) Sir Philip Hampton as the company's new chairman, according to local reports.

Several UK media outlets have published stories suggesting GSK will this week officially announce Sir Philip (pictured) as chairman-designate, replacing Sir Christopher Gent when he steps down in 2015.

The news come at a time of pressure for GSK after the company was recently hit with a $487m fine for illegal marketing practices in China.

Sir Philip has served as chairman of the board at RBS since 2009, overseeing the company during a time of global economic collapse.

He has experience in a wide variety of industries, with previous roles including chairman of Sainsbury's and as group finance directory at Lloyds TSB, BT Group, BG Group, British Gas and British Steel.

He is also a former chairman of UK Financial Investments Limited, which manages the UK Government's shareholdings in banks.


25th September 2014

From: Research, Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Virgo Health

Virgo Health is an award-winning global healthcare communications and medical education agency comprising specialists with some of the best skills,...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics